Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Ayman Alhejazi

Achievements

—Sickle cell disease research: Participated in published research examining outcomes following non-myeloablative allogeneic transplantation in adults with severe sickle cell disease.
—Consultant Adult Hematologist and Stem Cell Transplant Specialist at King Abdulaziz Medical City (KAMC-NGHA, Riyadh, Saudi Arabia).
—Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) in Internal Medicine and Adult Hematology.

Dr. Ayman Alhejazi

Consultant Haematologist

King Abdulaziz Medical City

About

Dr. Ayman Alhejazi is a distinguished consultant adult hematologist, bone marrow transplant physician, and clinical researcher whose work has significantly influenced the practice of hematologic oncology across the Kingdom of Saudi Arabia and the broader Gulf Cooperation Council (GCC) region. He earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree before undertaking rigorous postgraduate residency and fellowship training in North America,attaining Fellowship status with the Royal College of Physicians and Surgeons of Canada (FRCPC) in both Internal Medicine and Adult Hematology, with specialized subspecialty training in Stem Cell Transplantation and Cellular Therapy.

Throughout a clinical career spanning over two decades at King Abdulaziz Medical City (KAMC-NGHA) in Riyadh, Dr.Alhejazi has established himself as a leading regional authority in the management of multiple myeloma,relapsed/refractory Hodgkin and non-Hodgkin lymphomas, chronic lymphocytic leukemia (CLL), and severe hemoglobinopathies such as sickle cell disease. His operative clinical work focuses on autologous and allogeneic hematopoietic stem cell transplantation, non-myeloablative conditioning protocols, and navigating novel immunotherapies including bispecific antibodies and CAR-T cell therapies.

Beyond his direct bedside clinical care, Dr. Alhejazi is a prolific scientific contributor and research leader. He has authored and co-authored over eighty peer-reviewed articles and consensus guidelines in major journals such as Frontiers in Medicine, Leukemia Research, Clinical Lymphoma, Myeloma & Leukemia, and JCO Global Oncology. His research contributions encompass real-world registry studies evaluating pharmacotherapy in multiple myeloma (such as the Greater Gulf REPAIR Study), consensus statements on bispecific antibody utilization, treatment-free remission (TFR) in chronic myeloid leukemia, and clinical management strategies for vulnerable immunocompromised cancer populations.

Dr. Alhejazi also holds key administrative and academic advisory roles, contributing directly to regional oncology guidelines, health system quality improvement projects (such as reducing futile acute care services for terminally ill patients), and training the next generation of hematologists and bone marrow transplant fellows at KSAU-HS.

At major regional scientific congresses, most notably the 7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview, Dr. Ayman Alhejazi is a featured keynote speaker and panel expert. Translating complex translational immunology and global trial data into daily clinical practice, he provides hematologists, oncologists, pathologists, and transplant specialists with practical, actionable strategies to optimize disease outcomes and elevate standards of care for patients across the region.

Events & Activities

7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview
Oct 9, 2026
In-Person

7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview

Saudi Society of Blood & Marrow Transplantation (SSBMT)

  • CME
  • Novotel Dhahran Hotel & Residences
Oct 9, 2026
In-Person

7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview

Free

This two-day SSBMT conference brings together regional and international experts to share the latest developments in lymphoma, multiple myeloma, and hematopathology. Through expert-led lectures, scientific discussions, and clinical case sessions, the program explores advances in diagnosis, treatment, and emerging approaches to managing complex hematological disorders.

Saudi Society of Blood & Marrow Transplantation (SSBMT)

  • 2 Days
  • Novotel Dhahran Hotel & Residences
2nd Emirates MSK Radiology National Conference
Sep 26, 2026
Hybrid

2nd Emirates MSK Radiology National Conference

SSMC Training Academy

  • 8.15 CME
  • SSMC Auditorium, Sheikh Shakhbout Medical City, Abu Dhabi, UAE
Sep 26, 2026
Hybrid

2nd Emirates MSK Radiology National Conference

AED 600

A hybrid conference focusing on upper limb MSK imaging, featuring interactive DICOM workshops, case-based learning, and hands-on ultrasound interventions.

SSMC Training Academy

  • 2 Days
  • SSMC Auditorium, Sheikh Shakhbout Medical City, Abu Dhabi, UAE
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education